Literature DB >> 19692625

Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis.

Vidhya Novem1, Guanghou Shui, Dongling Wang, Anne K Bendt, Siew Hoon Sim, Yichun Liu, Tuck Weng Thong, Suppiah Paramalingam Sivalingam, Eng Eong Ooi, Markus R Wenk, Gladys Tan.   

Abstract

Burkholderia pseudomallei, the etiological agent of melioidosis, is a facultative intracellular pathogen. As B. pseudomallei is a gram-negative bacterium, its outer membrane contains lipopolysaccharide (LPS) molecules, which have been shown to have low-level immunological activities in vitro. In this study, the biological activities of B. pseudomallei LPS were compared to those of Burkholderia thailandensis LPS, and it was found that both murine and human macrophages produced levels of tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-10 in response to B. pseudomallei LPS that were lower than those in response to B. thailandensis LPS in vitro. In order to elucidate the molecular mechanisms underlying the low-level immunological activities of B. pseudomallei LPS, its lipid A moiety was characterized using mass spectrometry. The major lipid A species identified in B. pseudomallei consists of a biphosphorylated disaccharide backbone, which is modified with 4-amino-4-deoxy-arabinose (Ara4N) at both phosphates and penta-acylated with fatty acids (FA) C(14:0)(3-OH), C(16:0)(3-OH), and either C(14:0) or C(14:0)(2-OH). In contrast, the major lipid A species identified in B. thailandensis was a mixture of tetra- and penta-acylated structures with differing amounts of Ara4N and FA C(14:0)(3-OH). Lipid A species acylated with FA C(14:0)(2-OH) were unique to B. pseudomallei and not found in B. thailandensis. Our data thus indicate that B. pseudomallei synthesizes lipid A species with long-chain FA C(14:0)(2-OH) and Ara4N-modified phosphate groups, allowing it to evade innate immune recognition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692625      PMCID: PMC2756838          DOI: 10.1128/CVI.00472-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  59 in total

1.  The many facets of melioidosis.

Authors:  T Dharakul; S Songsivilai
Journal:  Trends Microbiol       Date:  1999-04       Impact factor: 17.079

2.  Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide.

Authors:  Alba Silipo; Antonio Molinaro; Paola Cescutti; Emiliano Bedini; Roberto Rizzo; Michelangelo Parrilli; Rosa Lanzetta
Journal:  Glycobiology       Date:  2004-12-15       Impact factor: 4.313

3.  Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei.

Authors:  M D Smith; B J Angus; V Wuthiekanun; N J White
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 4.  Immunity to Burkholderia pseudomallei.

Authors:  Willem J Wiersinga; Tom van der Poll
Journal:  Curr Opin Infect Dis       Date:  2009-04       Impact factor: 4.915

5.  Inhibition of Salmonella enterica serovar Typhimurium lipopolysaccharide deacylation by aminoarabinose membrane modification.

Authors:  Kiyoshi Kawasaki; Robert K Ernst; Samuel I Miller
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

Review 6.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins.

Authors:  Susu M Zughaier; Shanta M Zimmer; Anup Datta; Russell W Carlson; David S Stephens
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 8.  LPS, TLR4 and infectious disease diversity.

Authors:  Samuel I Miller; Robert K Ernst; Martin W Bader
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

9.  Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis.

Authors:  Michelle Nelson; Joann L Prior; M Stephen Lever; Helen E Jones; Timothy P Atkins; Richard W Titball
Journal:  J Med Microbiol       Date:  2004-12       Impact factor: 2.472

10.  Legionella pneumophila mediated activation of dendritic cells involves CD14 and TLR2.

Authors:  Sibylla Braedel-Ruoff; Marion Faigle; Norbert Hilf; Birgid Neumeister; Hansjörg Schild
Journal:  J Endotoxin Res       Date:  2005
View more
  35 in total

1.  Alteration of the phenotypic and pathogenic patterns of Burkholderia pseudomallei that persist in a soil environment.

Authors:  Yao-Shen Chen; Wun-Ju Shieh; Cynthia S Goldsmith; Maureen G Metcalfe; Patricia W Greer; Sherif R Zaki; Hsin-Hou Chang; Hao Chan; Ya-Lei Chen
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

Review 2.  Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.

Authors:  Herbert P Schweizer
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

3.  Development of reagents and assays for the detection of pathogenic Burkholderia species.

Authors:  Omar Qazi; Mridula Rani; Annie J Gnanam; Thomas W Cullen; Christopher M Stead; Haley Kensing; Kate McCaul; Sarah Ngugi; Joann L Prior; Alexandria Lipka; Judit M Nagy; C Whitlock Gregory; Barbara M Judy; Sarah V Harding; Richard W Titball; Sachdev S Sidhu; M Stephen Trent; G Barrie Kitto; Alfredo Torres; D Mark Estes; Brent Iverson; George Georgiou; Katherine A Brown
Journal:  Faraday Discuss       Date:  2011       Impact factor: 4.008

4.  Bilayer Properties of Lipid A from Various Gram-Negative Bacteria.

Authors:  Seonghoon Kim; Dhilon S Patel; Soohyung Park; Joanna Slusky; Jeffery B Klauda; Göran Widmalm; Wonpil Im
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

Review 5.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

6.  Canonical Inflammasomes Drive IFN-γ to Prime Caspase-11 in Defense against a Cytosol-Invasive Bacterium.

Authors:  Youssef Aachoui; Yuji Kajiwara; Irina A Leaf; Dat Mao; Jenny P-Y Ting; Jörn Coers; Alan Aderem; Joseph D Buxbaum; Edward A Miao
Journal:  Cell Host Microbe       Date:  2015-08-27       Impact factor: 21.023

Review 7.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

8.  Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Front Microbiol       Date:  2011-07-22       Impact factor: 5.640

Review 9.  Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Front Cell Infect Microbiol       Date:  2011-07-22       Impact factor: 5.293

10.  Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.

Authors:  Joshua K Stone; Mark Mayo; Stephanie A Grasso; Jennifer L Ginther; Stephanie D Warrington; Christopher J Allender; Adina Doyle; Shalamar Georgia; Mirjam Kaestli; Stacey M Broomall; Mark A Karavis; Joseph M Insalaco; Kyle S Hubbard; Lauren A McNew; Henry S Gibbons; Bart J Currie; Paul Keim; Apichai Tuanyok
Journal:  BMC Microbiol       Date:  2012-11-05       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.